• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

内皮衍生舒张因子在体外对人全血及在体内对大鼠均能抑制血小板聚集。

Endothelium-derived relaxing factor inhibits platelet aggregation in human whole blood in vitro and in the rat in vivo.

作者信息

Bhardwaj R, Page C P, May G R, Moore P K

机构信息

Department of Pharmacology, King's College (KQC), University of London, U.K.

出版信息

Eur J Pharmacol. 1988 Nov 15;157(1):83-91. doi: 10.1016/0014-2999(88)90474-8.

DOI:10.1016/0014-2999(88)90474-8
PMID:3266154
Abstract

Carbachol (0.03-10 microM) or histamine (0.06-10 microM) challenge of indomethacin-pretreated rat aortic rings inhibited ADP-induced aggregation of platelets suspended in anticoagulated human whole blood. The maximum inhibition of platelet aggregation achieved with either drug was approximately 50%. No such inhibition was observed in rat aortic rings rubbed to remove endothelial cells or in intact vessels preincubated with nordihydroguaiaretic acid (NDGA, 10 microM), mepacrine (10 microM) or methylene blue (100 microM). Intravenously (i.v.) injected carbachol (0.5-5 micrograms/kg) also inhibited ADP-induced accumulation of 111indium-labelled platelets in the pulmonary circulation of urethane-anaesthetised rats. This effect of carbachol was inhibited by i.v. injected methylene blue (10 mg/kg) but unaffected by indomethacin (3 mg/kg) or hexamethonium (10 mg/kg) suggesting that PGI2 or adrenaline release did not account for the inhibition of platelet activation observed. Similarly, the platelet inhibitory effect of carbachol in vivo was not related to increased pulmonary vascular blood flow (assessed by accumulation of 111indium-labelled erythrocytes) or blood fibrinolytic activity (measured by euglobulin clot bioassay). The present results suggest that endothelium-derived relaxing factor or a like substance inhibits human platelet aggregation in vitro and rat platelet aggregation in vivo.

摘要

用卡巴胆碱(0.03 - 10微摩尔)或组胺(0.06 - 10微摩尔)刺激经消炎痛预处理的大鼠主动脉环,可抑制悬浮于抗凝人全血中的血小板由二磷酸腺苷(ADP)诱导的聚集。两种药物对血小板聚集的最大抑制率约为50%。在擦去内皮细胞的大鼠主动脉环或预先用去甲二氢愈创木酸(NDGA,10微摩尔)、米帕林(10微摩尔)或亚甲蓝(100微摩尔)孵育的完整血管中未观察到这种抑制作用。静脉注射卡巴胆碱(0.5 - 5微克/千克)也可抑制乌拉坦麻醉大鼠肺循环中由ADP诱导的111铟标记血小板的聚集。卡巴胆碱的这种作用可被静脉注射的亚甲蓝(10毫克/千克)抑制,但不受消炎痛(3毫克/千克)或六甲铵(10毫克/千克)影响,这表明观察到的血小板活化抑制作用并非由前列环素(PGI2)或肾上腺素释放所致。同样,卡巴胆碱在体内的血小板抑制作用与肺血管血流量增加(通过111铟标记红细胞的聚集评估)或血液纤溶活性(通过优球蛋白凝块生物测定法测量)无关。目前的结果表明,内皮源性舒张因子或类似物质在体外可抑制人血小板聚集,在体内可抑制大鼠血小板聚集。

相似文献

1
Endothelium-derived relaxing factor inhibits platelet aggregation in human whole blood in vitro and in the rat in vivo.内皮衍生舒张因子在体外对人全血及在体内对大鼠均能抑制血小板聚集。
Eur J Pharmacol. 1988 Nov 15;157(1):83-91. doi: 10.1016/0014-2999(88)90474-8.
2
Endothelium-derived relaxing factor and the effects of acetylcholine and histamine on resistance blood vessels.内皮源性舒张因子以及乙酰胆碱和组胺对阻力血管的影响。
Br J Pharmacol. 1988 Nov;95(3):835-43. doi: 10.1111/j.1476-5381.1988.tb11712.x.
3
Platelet inhibition by endothelium-derived relaxing factor from the rabbit perfused aorta.兔灌注主动脉中内皮衍生舒张因子对血小板的抑制作用。
Br J Pharmacol. 1988 Dec;95(4):1308-14. doi: 10.1111/j.1476-5381.1988.tb11769.x.
4
N-acetylcysteine potentiates platelet inhibition by endothelium-derived relaxing factor.N-乙酰半胱氨酸可增强内皮源性舒张因子对血小板的抑制作用。
Circ Res. 1989 Sep;65(3):789-95. doi: 10.1161/01.res.65.3.789.
5
Vasorelaxant and antiaggregatory properties of the endothelium: a comparative study in normocholesterolaemic and hereditary and dietary hypercholesterolaemic rabbits.内皮的血管舒张和抗聚集特性:正常胆固醇血症以及遗传性和饮食性高胆固醇血症兔的比较研究
Br J Pharmacol. 1996 Dec;119(7):1470-6. doi: 10.1111/j.1476-5381.1996.tb16060.x.
6
Endothelin-1 inhibits platelet aggregation in vivo: a study with 111indium-labelled platelets.内皮素-1在体内抑制血小板聚集:一项用铟-111标记血小板的研究。
Br J Pharmacol. 1990 Feb;99(2):303-8. doi: 10.1111/j.1476-5381.1990.tb14699.x.
7
Co-axial bioassay of a smooth muscle relaxant factor released from guinea-pig tracheal epithelium.豚鼠气管上皮释放的平滑肌舒张因子的同轴生物测定。
Br J Pharmacol. 1989 Jan;96(1):117-24. doi: 10.1111/j.1476-5381.1989.tb11791.x.
8
In vivo EDRF activity influences platelet function.体内内皮舒张因子活性影响血小板功能。
Br J Pharmacol. 1988 Aug;94(4):1020-2. doi: 10.1111/j.1476-5381.1988.tb11616.x.
9
Endothelium-derived relaxing factor from cultured human endothelial cells inhibits aggregation of human platelets.来自培养的人内皮细胞的内皮衍生舒张因子抑制人血小板的聚集。
Thromb Res. 1987 Sep 1;47(5):561-71. doi: 10.1016/0049-3848(87)90361-6.
10
Detergent and methylene blue affect endothelium-dependent vasorelaxation and pressure/flow relations in rat blood perfused mesenteric arterial bed.去污剂和亚甲蓝影响大鼠血液灌注肠系膜动脉床中内皮依赖性血管舒张及压力/血流关系。
Br J Pharmacol. 1988 Dec;95(4):1081-8. doi: 10.1111/j.1476-5381.1988.tb11742.x.

引用本文的文献

1
The mitochondrial thioredoxin reductase system (TrxR2) in vascular endothelium controls peroxynitrite levels and tissue integrity.血管内皮中的线粒体硫氧还蛋白还原酶系统(TrxR2)控制过氧亚硝酸盐水平和组织完整性。
Proc Natl Acad Sci U S A. 2021 Feb 16;118(7). doi: 10.1073/pnas.1921828118.
2
The anti-aggregating effect of BAY 41-2272, a stimulator of soluble guanylyl cyclase, requires the presence of nitric oxide.BAY 41-2272(一种可溶性鸟苷酸环化酶的刺激剂)的抗聚集作用需要一氧化氮的存在。
Br J Pharmacol. 2010 Nov;161(5):1044-58. doi: 10.1111/j.1476-5381.2010.00943.x.
3
Vasorelaxant and antiaggregatory properties of the endothelium: a comparative study in normocholesterolaemic and hereditary and dietary hypercholesterolaemic rabbits.
内皮的血管舒张和抗聚集特性:正常胆固醇血症以及遗传性和饮食性高胆固醇血症兔的比较研究
Br J Pharmacol. 1996 Dec;119(7):1470-6. doi: 10.1111/j.1476-5381.1996.tb16060.x.
4
Inhibition of superoxide anion release from circulating neutrophils by L-arginine in man.L-精氨酸对人体循环中性粒细胞超氧阴离子释放的抑制作用。
Clin Investig. 1993 Dec;71(12):985-9. doi: 10.1007/BF00180028.
5
L-NG-nitro arginine (L-NOARG), a novel, L-arginine-reversible inhibitor of endothelium-dependent vasodilatation in vitro.L-NG-硝基精氨酸(L-NOARG),一种新型的、体外可逆转内皮依赖性血管舒张的L-精氨酸抑制剂。
Br J Pharmacol. 1990 Feb;99(2):408-12. doi: 10.1111/j.1476-5381.1990.tb14717.x.
6
Endothelin-1 inhibits platelet aggregation in vivo: a study with 111indium-labelled platelets.内皮素-1在体内抑制血小板聚集:一项用铟-111标记血小板的研究。
Br J Pharmacol. 1990 Feb;99(2):303-8. doi: 10.1111/j.1476-5381.1990.tb14699.x.
7
The pharmacological modulation of thrombin-induced cerebral thromboembolism in the rabbit.兔凝血酶诱导的脑血栓栓塞的药理学调节
Br J Pharmacol. 1992 May;106(1):133-8. doi: 10.1111/j.1476-5381.1992.tb14305.x.
8
The role of nitric oxide as an endogenous regulator of platelet and neutrophil activation within the pulmonary circulation of the rabbit.一氧化氮作为家兔肺循环中血小板和中性粒细胞激活的内源性调节因子的作用。
Br J Pharmacol. 1991 Mar;102(3):759-63. doi: 10.1111/j.1476-5381.1991.tb12246.x.